Pfizer Deferoxamine Mesylate Injectable

Pfizer's Deferoxamine Mesylate Injectable is a crucial medical tool designed for the treatment of chronic iron overload and acute iron intoxication. Packaged in a single dose, 2 g concentration, glass fliptop vial, it assures both quality and precision in administration. Each glass vial is crafted for efficiency and ease of use, ensuring an optimal experience for healthcare providers.

The vials are conveniently organized in a box of four, facilitating broader treatment regimes when dealing with conditions such as transfusion-dependent anemias that lead to iron overload. This injectable solution is vital for binding excess iron and promoting its elimination from the body, thereby protecting patients from the adverse effects of iron accumulation.

• High purity and efficacy ensure reliable patient outcomes when treating iron overload conditions.
• Easy administration with a fliptop vial design for precise dosing and reduced spillage risk.

• Deferoxamine Mesylate is used for the treatment of chronic iron overload due to transfusion-dependent anemias and acute iron intoxication. It helps to bind excess iron in the bloodstream and promote its elimination from the body.

1. How should Deferoxamine Mesylate be stored?
Store Deferoxamine Mesylate in a refrigerator between 2°C to 8°C (36°F to 46°F) and protect it from light.

2. Can Deferoxamine Mesylate be used for all ages?
Deferoxamine Mesylate is suitable for children and adults, but dosage may be adjusted based on weight and medical condition, always follow healthcare provider guidance.